Literature DB >> 19416001

Is hypothyroidism a clinically relevant toxicity of tyrosine kinase inhibitors?

Francesco Torino, Salvatore Maria Corsello, Raffaele Longo, Agnese Barnabei, Giampietro Gasparini.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19416001     DOI： 10.1089/thy.2008.0367

Source DB:  PubMed          Journal:  Thyroid        ISSN： 1050-7256            Impact factor:   6.568


× No keyword cloud information.
  3 in total

1.  Hypothyroidism correlates with a better prognosis in metastatic renal cancer patients treated with sorafenib or sunitinib.

Authors:  L M Riesenbeck; S Bierer; I Hoffmeister; T Köpke; P Papavassilis; L Hertle; B Thielen; E Herrmann
Journal:  World J Urol       Date:  2010-12-14       Impact factor: 4.226

2.  Extreme hypothyroidism associated with sunitinib treatment for metastatic renal cancer.

Authors:  Egidio Del Fabbro; Rony Dev; Maria E Cabanillas; Naifa L Busaidy; EdenMae C Rodriguez; Eduardo Bruera
Journal:  J Chemother       Date:  2012-08       Impact factor: 1.714

3.  Hypothyroidism Side Effect in Patients Treated with Sunitinib or Sorafenib: Clinical and Structural Analyses.

Authors:  Mao Shu; Xiaoli Zai; Beina Zhang; Rui Wang; Zhihua Lin
Journal:  PLoS One       Date:  2016-01-19       Impact factor: 3.240
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.